Back

SARS-CoV-2 Omicron efficiently infects human airway, but not alveolar epithelium

Lamers, M. M.; Mykytyn, A. Z.; Breugem, T. I.; Groen, N.; Knoops, K.; Schipper, D.; van Acker, R.; van den Doel, P. B.; Bestebroer, T.; Koopman, C. D.; Reusken, C.; Muraro, M. J.; GeurtsvanKessel, C. H.; van Royen, M. E.; Peters, P. J.; Zhang, J.; Haagmans, B. L.

2022-01-20 microbiology
10.1101/2022.01.19.476898 bioRxiv
Show abstract

In late 2021, the highly mutated SARS-CoV-2 Omicron variant emerged, raising concerns about its potential extensive immune evasion, increased transmissibility and pathogenicity. Here, we used organoids of the human airways and alveoli to investigate Omicrons fitness and replicative potential in comparison with earlier SARS-CoV-2 variants. We report that Omicron replicates more rapidly in the airways and has an increased fitness compared to the early 614G variant and Delta. In contrast, Omicron did not replicate productively in human alveolar type 2 cells. Mechanistically, we show that Omicron does not efficiently use TMPRSS2 for entry or spread through cell-cell fusion. Altogether, our data show that Omicron has an altered tropism and protease usage, potentially explaining its higher transmissibility and decreased pathogenicity.

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.